Sanofi Pasteur to develop COVID-19 vaccine with US governmen...

Sanofi Pasteur, the global vaccines business unit of the French drug maker Sanofi, has joined forces with a US government department to develop a novel COVID-19 coronavirus vaccine.

CMO Nathwani out as Sanofi's Hudson slims top executive team

Sanofi's Dupixent funded in Wales and Scotland for adolescen...

Sanofi’s Dupixent (dupilumab) has been cleared for NHS funding in Wales and Scotland in adolescents with severe eczema, also known as atopic dermatitis.

Lilly swoops on Dermira to claim Dupixent rival

Sanofi Genzyme UK medical boss Marc Moodley discusses oncolo...

Marc Moodley has worked at Sanofi since 2018 and is the new medical head, UK and Ireland for the company’s Genzyme unit.

Sanofi axes diabetes R&D, focuses on 'transformative' therap...

Take a look at Sanofi’s balance sheet and it’s obvious which way the wind is blowing – sales in its once mighty diabetes franchise are sliding, while newer medicines such as its eczema and